baber/WOPTO huggingface dataset:
Patent JP-2002514188-A (JP)
Title: 標的とする共有結合極性脂質複合体
IPC: A61K31/196
Filed: 1997-10-27
Abstract: (57)【要約】
本発明は、生理学的保護部位における細胞および組織に薬を薬物動態的に有用な水準で導入することを容易にする方法、および細胞内の特定の小器官に薬を差し向ける方法も記載する。極性脂質／薬複合体標的化発明は、従来技術で知られている他の薬標的化方法を超える利点を提供する。何故なら、本発明は、治療的効果を達成するために現在投与されているよりも大幅に低い全身的水準の投与後に治療有効水準に達することができるような生理学的保護部位における薬濃度を提供するからである。この技術は、向精神薬、向神経薬および神経薬、薬剤および化合物を用いる使用で、そのような薬を血液脳関門を通過するように迅速かつ効果的に導入するのに適切である。さらに、本発明は、脳および中枢神経系において、本発明の複合体を含む向精神薬、向神経薬および神経薬、薬剤および化合物を保持および遅延酵素的放出するための手段を提供する。
Patent JP-H10511546-A (JP)
Title: Ｅ２結合蛋白質
IPC: C12P21/02
Filed: 1995-12-22
Abstract: (57)【要約】
Ｅ２−ＢＰポリペプチド、Ｅ２−ＢＰポリペプチドをコードする核酸、及びこれらの利用。
Patent JP-H09511388-A (JP)
IPC: C12N15/85
Filed: 1995-01-27
Abstract: A transgenic non-human eukaryotic animal whose germ cells and somatic cells contain the amyloid precursor protein sequence introduced into the animal, or an ancestor of the animal, at an embryonic stage.
Patent JP-H09508406-A (JP)
IPC: C12P19/34
Filed: 1995-02-03
Abstract: A process for the depletion or removal of endotoxins from preparations containing active ingredients designated for therapeutical use which are obtained from natural sources by genetic engineering and/or biotechnology by treatment with chromatographic material wherein said natural sources are lysed, the fractions obtained are optionally centrifuged, filtrated or treated with affinity chromatographic methods; said fractions are preincubated with an aqueous salt solution and detergents, treated with anion exchange material and then washed with another salt solution, and the active ingredients are eluted from the anion exchanger, followed by further purification in a per se known manner.
Patent JP-H10512051-A (JP)
Title: 不安定状態で原子炉を作動させるための方法および装置
IPC: G21D3/08
Filed: 1996-01-08
Abstract: (57)【要約】
沸騰水型原子炉の過渡的な不安定状態を減衰させるように、振動する中性子束が測定され、また多数の振動周期を越えての第１の限界値の超過後に振動の振幅増大レートが決定される。振幅増大レートに関係して振動する中性子束に対する別の（特に振幅増大レートに関係する）限界値の超過後に、スクラムが必要になる以前に振動を早期に減衰させる種々の安定化ストラテジーからの選択が行われる。安定化措置のハイアラーキ：制御部での出力上昇の阻止、制御された徐々の出力減少“部分的スクラム”による急速な出力減少が可能となる。不安定な状態の監視は、炉心にわたって配分されており、冗長性をもってそれぞれ１つの範囲内の中性子束を測定するセンサのシステムにより行われる。センサはその際に冗長性をもって動作する多数のシステムに作用し、その際に各センサの信号はそれぞれこれらの冗長性をもつシステムのただ１つにおいてのみ有効である。
Patent JP-2001504566-A (JP)
Title: タービンの負荷切替過程を調節するためのタービン制御装置および方法
IPC: F01D21/12
Filed: 1997-11-07
Abstract: (57)【要約】
本発明はタービン（７）の負荷切替過程を調節するためのタービン制御装置であって、制限ユニット（３）を有し、それに負荷切替過程の継続時間tVを可変に設定するための量が供給されるタービン制御装置に関する。制限ユニット（３）のなかで、継続時間tV中に負荷切替過程を実行するためのタービン制御量（ＶＡＲ）の決定が、最大許容材料ストレスを考慮に入れて行われる。疲労ユニット（４）において、タービン制御量（ＶＡＲ）に相応して実行すべき負荷切替過程の材料疲労が前もって求められる。本発明はさらにタービン（７）の負荷切替過程を調節するための方法に関する。
Patent JP-2000501736-A (JP)
Title: ロサルタンの新用途
IPC: A61K31/415
Filed: 1996-12-09
Abstract: (57)【要約】
治療有効量のロサルタン、その活性代謝物ＥＸＰ３１７４、又はこれら化合物の医薬的に許容可能な塩を虚血発作後の心臓機能回復の向上に使用する。
Patent JP-H09500225-A (JP)
IPC: G07F7/12
Filed: 1994-04-08
Abstract: A method and apparatus is disclosed for determining the remanent noise in a magnetic medium by DC saturation of a region thereof and measurement of the remaining DC magnetization. A conventional magnetic recording transducer may be used to determine the remanent noise. Upon determination, the remanent noise may then be digitized and recorded on the same magnetic medium to thereby "fingerprint" the magnetic medium. This "fingerprint" may then be later used to verify and authenticate the magnetic medium as being an original. In such manner, any magnetic medium, or any object having an associated magnetic medium, may be "fingerprinted" including credit cards, computer programs, compact discs, videotapes, cassette tapes, etc.
Patent JP-2000506583-A (JP)
IPC: F02G1/055
Filed: 1997-03-21
Abstract: PCT No. PCT/EP97/01428 Sec. 371 Date May 6, 1999 Sec. 102(e) Date May 6, 1999 PCT Filed Aug. 21, 1997 PCT Pub. No. WO97/37119 PCT Pub. Date Oct. 9, 1997In a Stirling engine with a cylinder head which can be heated, with a plurality of heating pipes bent in approximately U shape and with a cooler the the heat transfer to the heating pipes and the efficiency of the cooler are improved. This For this purpose the outwardly directed pipe sections (4c) of the heating pipes (4) through which the working medium flows are provided at least locally with a ceramic backing (11) for optimization of the flow (10) of the heating gas and the cooler is in the form of a light metal body (20) with radial ribs (23) within a pot-like housing (21), through which cooling water flows. The spacing of the radial ribs (23) from one another is greater than the gap (25) between the pot inner wall and the outer radial ribs bounding wall.
Patent JP-H11501831-A (JP)
IPC: A47C27/10
Filed: 1996-03-14
Abstract: A supporting device such as, for instance, a cushion, comprising a space formed by a flexible envelope and filled with a plurality of elements. The elements in the space are movable relative to each other and each consist of a gas-filled, flexible and thin-walled covering of gastight design, so that the elements are deformable for distributing a load over the supporting device. The covering of a number of elements is manufactured from at least substantially nonelastic material. These elements are each filled with the gas for 50-98 percent of their maximum volume and have a volume of from 10 cm<3> to 100 cm<3>. <IMAGE>
Patent JP-2000505942-A (JP)
Title: ゼロ電流回路遮断
IPC: H01H73/00
Filed: 1997-12-16
Abstract: (57)【要約】
多極遮断器の各々の極が、過電流発生時に遮断器接点を個別に開離するように構成される。遮断器引外し装置内のディジタル処理装置が、個別の極内の関連する相電流のゼロ交差の発生を判定して、最低の可能な電流値で接点の開離を開始させる。
Patent JP-H09512489-A (JP)
Title: 研磨剤混合物供給システム
IPC: B24C1/04
Filed: 1995-04-28
Abstract: (57)【要約】
従来の研磨剤混合物加圧システムは、圧力容器（１５）、前記区画に接続されたノズル（１３）、圧力をかけられた液のための入口（１２）、区画の内容物をノズルに駆動するもの、および研磨剤混合物の供給源を含む。これは圧力容器の内部を可撓性ダイヤフラム（１９）によってある区画を規定するように分けることで改良される。この区画はその圧力をさまざまな目的のために制御することができる。たとえばノズルで研磨剤混合物を迅速に射出するため急激な圧力変化を生じさせることもでき、または供給源から研磨剤粒子を吸い込むこともできる。
Patent JP-H10509475-A (JP)
Title: 原子（または基）移動・ラジカル重合に基づく新規な共重合体および新規な重合方法
IPC: C08F4/06
Filed: 1996-03-19
Abstract: (57)【要約】
遷移金属(例えば、Ｃu(I)/Ｃu(II))との間のレドックス反応に基づく新しい重合方法(原子移動ラジカル重合またはＡＴＲＰ)は、スチレン、(メタ)アクリレートおよび他のラジカル重合化単量体の"リビング"または制御ラジカル重合を提供する。モデルハロゲン原子移動前駆体(開始剤)として様々な簡単な有機ハロゲン化物を使用し、モデルハロゲン原子移動促進剤(触媒)として遷移金属錯体を使用して、"リビング"ラジカル重合を行うと、△[Ｍ]/[I] o (Ｍn>10 5 以上)により予め決められた数平均分子量および驚くほど狭い分子量分布(Ｍw/Ｍn)1.15を有する(共)重合体が得られる。ＡＴＲＰにフリーラジカル中間生成物が関与することは、末端基の分析および重合の立体化学により立証される。さらに、様々なトポロジーを有する重合体[例えば、ブロック、ランダム、星型、末端官能性、連鎖中官能性の共重合体(例えば、スチレンと(メタ)アクリル酸メチルの共重合体など)]は本発明方法を使って合成された。本発明の範囲内である重合生成物はプラスチック、エラストマー、接着剤、乳化剤、熱可塑性エラストマーなどとして広く使用される。
Patent JP-2001508479-A (JP)
IPC: B01D67/00
Filed: 1998-01-08
Abstract: The manufacture of porous molded bodies by sintering of a mixture of powderous thermoplastic polymers and a liquid is described, the boiling point of the latter being at least equal to or higher than the sintering temperature. Sintering takes places in a mould, the process may be performed continuously and is suitable for the manufacture of porous molded bodies such as pipes, panels and the like which can be used as filter, gas distribution, air distribution, coalescing elements, as suction elements for oil, as carriers of active substances etc.
Patent JP-H11503345-A (JP)
Title: マスカラ用ブラシ付き容器
IPC: A45D40/26
Filed: 1996-04-12
Abstract: (57)【要約】
マスカラ用のブラシ付き容器が開示されている。非円形の開口部（４）を備えたスリーブ（３）が容器（１）の首部（２）内に回転自在に装着され、開口部（４）の形状に整合する非円形の断面形状を有するブラシ（８）が、非円形で前記開口部（４）に適合する断面形状を有するロッド（６）に支持されている。ロッドはキャップ（５）に取り付けられ、ブラシ（８）が容器（１）の首部（２）内に挿入されると共に、過剰のマスカラがスリーブ（３）の開口部（４）においてブラシ（８）から拭き取られるようにブラシが引き抜かれる。このため、マスカラは、まつ毛のみに正確に塗布される。
Patent JP-2001506189-A (JP)
Title: 半透明の合成材料の対象物に印を付ける方法、特にこのように印を付けた眼用レンズ、および対応した読み取り装置
IPC: G02C13/00
Filed: 1998-01-26
Abstract: (57)【要約】
本発明は、半透明合成材料から成る対象物（１０）の印付けと、それに関連した読み取り装置に関する。本発明は、縦穴（２０）の形状のエッチングセルにあり、エッチングしたそれぞれのセル（１４）は、この縦穴（２０）の底部（２１）上で隆起している、少なくとも一つの突出部（２２）を有することを特徴とする。本発明は、特に、眼用レンズに印付けするのに有効である。
Patent JP-2000506863-A (JP)
IPC: A61P13/02
Filed: 1997-03-07
Abstract: This invention provides methods for the treatment or prevention of interstitial cystitis or urethral syndrome in a mammal which comprise administering to a mammal in need thereof an effective amount of duloxetine.
Patent JP-2000506719-A (JP)
Title: シリコン制御整流器フルブリッジ回路を有するインバータ
IPC: H02M7/483
Filed: 1997-03-18
Abstract: (57)【要約】
４つのシリコン制御整流器（SCR）スイッチを有するフルブリッジ回路、制御電圧信号を発生して該スイッチの各対を交互にオンにするための２つのパルス制御回路、タイムシーケンシング回路、及びパワースイッチ回路を備えた、直流電圧を交流電圧に変換するためのインバータ。フルブリッジ回路は、正の直流入力端子に直接接続され、かつパワースイッチ回路を介して負の直流入力端子に接続される。タイムシーケンシング回路は、第１のパルス制御回路を制御するための第１のパルス信号と、第２のパルス制御回路を制御するための第２のパルス信号を該第１のパルス信号と該第２のパルス信号が互いに逆相関係になるように発生する。タイムシーケンシング回路は、さらに、第１のパルス信号のパルスと第２のパルス信号のパルスの間の期間中パワースイッチ回路をオフにするための間欠サイクルパルス信号を発生する。本発明のインバータは、小型UPSシステム用として使用するのに好適な寸法及び重量にすることが可能であり、しかも安全で信頼性のある動作を提供する。
Patent JP-2001508490-A (JP)
Title: 照射硬化できる伝導性コーティング分散物、その製造法およびそれから作られるコーティング
IPC: C08L75/04
Filed: 1998-01-07
Abstract: (57)【要約】
本発明は、照射硬化できる樹脂および、分散剤中の電気伝導性粒子の分散物を含む電気伝導性組成物に関し、ここで電気伝導性粒子の分散物は、バインダーおよび電気伝導性ポリマーを含み、非イオン性安定剤によって安定化されている。本発明はまた、伝導性コーティングにおけるこの組成物の使用方法、本発明に係る組成物を使用して作られるコーティングおよびかかるコーティングを用いて全体的または部分的に塗膜された基体にも関する。
Patent JP-H11501362-A (JP)
Title: 抗菌剤でコートされたヒドロゲル形成吸収ポリマー
IPC: C08J7/06
Filed: 1996-11-14
Abstract: (57)【要約】
本発明はヒドロゲル形成吸収ポリマーと抗菌剤を含んでなり、ヒドロゲル形成吸収ポリマーが抗菌剤でコートされている、抗菌性ヒドロゲル形成吸収ポリマーに関する。本発明はこのような抗菌性ヒドロゲル形成吸収ポリマーの製造方法にも更に関する。本発明は抗菌性ヒドロゲル形成吸収ポリマーを含んでなる使い捨て吸収体にも更に関する。
Patent JP-2000509800-A (JP)
Title: 磨耗を減らすための表面粗さ（ｔｅｘｔｕｒｅ）のついたシール
IPC: F16J15/34
Filed: 1998-02-23
Abstract: (57)【要約】
シール（１０）には表面粗さ容貌体(textured features)（４１，４１'，４１'',４１'''）のついた接触面（３６）がある。接触面（３６）は適切にシールし、磨耗耐久性がある。接触面（３６）は、土石移動車両への適用に見られるような非常に厳しい環境のもとでも有効に働く。
Patent JP-2001518225-A (JP)
Title: ディスク状光学的記憶装置の書き込みおよび読み出し方法
IPC: G11B7/00
Filed: 1997-11-28
Abstract: (57)【要約】
本発明は、ディスク状光学的記憶装置を読み出しおよび書き込む方法に関する。この場合、少なくとも２つのアプリケーションを格納することができ、必要に応じて少なくとも１つの読み出しヘッドにより読み出すことができる。
Patent JP-2000510861-A (JP)
IPC: C07J17/00
Filed: 1997-05-26
Abstract: This invention describes the new 7alpha-(5-methylaminopentyl)-estratrienes of general formula Iin whichR2 stands for a hydrogen or fluorine atom,R17 stands for a hydrogen atom, a methyl or ethinyl group,n stands for 2, 3 or 4, andx stands for 0, 1 or 2.The new compounds are strong, pure antiestrogens and can be used for the production of pharmaceutical agents for treatment of estrogen-dependent diseases, for example, breast cancer, endometrial carcinoma, prostatic hyperplasia, anovulatory infertility and melanoma.
Patent JP-2002503366-A (JP)
Title: 電子スマートカード本体に電子モジュールを挿入する方法
IPC: G06K19/077
Filed: 1998-04-02
Abstract: (57)【要約】
本発明は、カード内に設けられた空洞(12)内に熱可塑性基板(131)上の電子モジュール(13)を挿入する方法に関する。本発明は次のステップを備える。a)前記電子モジュール(13)の熱可塑性基板(131)を前記カード本体(11)の熱可塑性材料に接着するため、前記空洞(12)内に接着剤(14)を置き；b)前記空洞(12)内に前記電子モジュール(13)を置き；c)前記電子モジュール(13)に加圧力(Ｆ)を加え、同時に前記電子モジュール(13)の前記熱可塑性基板(131)と接触する前記空洞(12)内の熱可塑性材料に超音波エネルギーを加える。本発明は、電子メモリーを有するカードを作るのに有用である。
Patent JP-2001523232-A (JP)
IPC: A61P15/00
Filed: 1998-04-13
Abstract: Peptides are provided which have improved duration of GnRH antagonistic properties and/or which can be synthesized more economically. These antagonists may be used in the same manner as the compounds of which they are analogs to regulate fertility and to treat steroid-dependent tumors and for other short-term and long-term treatment indications. One particularly effective peptide, a decapeptide analog of the GnRH antagonist Acyline, has the formula: Ac-D-2Nal-D-4Cpa-D-Dpr(methylcarbamoyl)-Ser-4Aph(acetyl)-D-4Aph(acetyl)-Leu-Lys(isopropyl)-Pro-D-Ala-NH2. It continues to exhibit very substantial suppression of LH secretion at 96 hours following injection. Other economically attractive and pharmacologically effective analogs have the formulas: Ac-D-2Nal-D-4Cpa-Xaa3-Ser-4Aph(acetyl)-D-4Aph(acetyl)-Leu-Lys(isopropyl)-Pro-D-Ala-NH2; and Ac-D-2Nal-D-4Cpa-Xaa3-Ser-4Aph(hydroorotyl)-D-4Aph(acetyl)-Leu-Lys(isopropyl)-Pro-D-Ala-NH2, wherein Xaa3 is D-Gln or Gln.
Patent JP-2000512312-A (JP)
Title: チアゾリジンジオンの改良製造方法及び新規なチアゾリジンジオン
IPC: C07D417/14
Filed: 1998-03-17
Abstract: (57)【要約】
本発明は、ＡがＣＨ＝ＣＨ又はＳを表し、ＷがＯを表し、ＸがＳ、Ｏ又はＮＲ 2 を表し、基Ｒ 2 が、水素又はＣ 1 −Ｃ 6 アルキルであり、ＹがＣＨ又はＮを表し、Ｒがナフチル、チエニル又はフェニル（これは、場合により、Ｃ 1 −Ｃ 3 アルキル、ＣＦ 3 、Ｃ 1 −Ｃ 3 アルコキシ、Ｆ、Ｃｌ又はブロモで、モノ−又はジ置換されている）を表し、Ｒ 1 が水素又はＣ 1 −Ｃ 6 アルキルを表し、そしてｎが１〜３を表す式(III)で示される化合物を製造するための改善された方法であって、Ａ、Ｗ、Ｘ、Ｙ、Ｒ、Ｒ 1 及びｎが前記と同義である一般式（IV）で示される化合物を、プロトン性溶媒中で、金属アルミニウムで還元する方法に関する、本発明は、また式（III）の新規化合物及びそれらの化合物を含む医薬に関する。
Patent MD-20040065-A (MD)
Title: Process for sun and wind power accumulation
Inventor: CIORA ANDREI
IPC: F24J2/00
Filed: 2004-03-26
Abstract: The invention relates to processes for power accumulation, in particular to a process for sun and wind power accumulation.The proposed process for sun and wind power accumulation is realized in several stages. From the wind plant and sun plant the electric current is applied to the control unit, then, depending on the power of the energy source, it is distributed to the hydrogen generators and to the control unit. The hydrogen generators with the capacity of 1…2 m3 per hour each are supplied with power from the control unit and with water from the reservoir. The oxygen and the hydrogen produced by the hydrogen generators are fed into the accumulation tanks under a pressure up to 3 atm. According as accumulated the oxygen and the hydrogen by means of a compressor are fed into the accumulator, where they are stored under a pressure of 200 atm. As far as necessary, the hydrogen in the accumulator is used as power raw material.
Patent MX-161862-A (MX)
Inventor: KASAT RADHAKRISHNA B
IPC: A61K8/28
Filed: 1984-07-19
Abstract: A creamy, heterogeneous, anhydrous antiperspirant product comprises (by weight) essentially 30 to 70% of a volatile silicone product carrier, 7 to 30% of a gelling agent and 12 to 30% of a physiologically acceptable anti-perspirant agent. Optional ingredients which can be included include surfactants, emollients, fillers, fragrances and coloring agents. The product may be made by mixing and heating the ingredients to a temperature above the melting point of the gelling agent, then cooling (while mixing thoroughly) to a temperature below the normal solidification point of the product.
Patent NZ-196897-A (NZ)
Title: 23-keto-derivatives of c-076 compounds,and composition useful against parasitic infections
Inventor: MROZIK H H
IPC: A61K31/355
Filed: 1981-04-23
Abstract: Derivatives of C-076 compounds are described in which the C-076 molecule, a series of macrolides, has the 23-hydroxy group thereof oxidized to the 23-keto group. The 23-keto compounds are prepared by selectively oxidizing the suitably protected 23-hydroxy compound using such oxidizing agents as pyridinium dichromate, chromic acid-dimethyl pyrazole, chromic acid, chromic acid-acetic acid, and the like. Alternatively, selective oxidation of the unprotected 23-hydroxy compound may be accomplished by placing the compound in soil. Further reaction of the oxidized C-076 compounds is also possible. The compounds thus produced have profound anthelmintic, insecticidal, ectoparasiticidal, and acaricidal activity. Compositions containing the described C-076 derivatives as the active ingredient thereof are also disclosed.
Patent NZ-221249-A (NZ)
Title: Making flexible plastics foam product with corrugated fibrous web insert and porous facing sheet
Inventor: MENARD M J
IPC: A61F13/15
Filed: 1987-07-29
Abstract: A process for making a formed flexible plastic foam product containing a fibrous web insert. In the process, a flexible ethylene containing sheet material is rapidly heated and die formed to provide multiple parallel shells integrally attached to the sheet. A fibrous web material having an elongated corrugated shape is filled with an absorbent powder, and is die cut to individual desired shapes which are inserted into the shells. A thin fibrous facing sheet material is placed over the powder-filled web and formed shell and the facing sheet is heat sealed onto the foam shell perimeter, after which the formed and filled foam shells are die cut from the plastic foam strip to produce the individual formed products. The process advantageously provides increased production rates at 10-30 cycles/minute for the formed products.
Patent NZ-229369-A (NZ)
Title: Modified baculovirus expression vector and its manufacture
Inventor: DEVAUCHELLE GERARD
IPC: C12N15/09
Filed: 1989-05-31
Abstract: The invention relates to a baculovirus modified by inserting into its genome a suitable restriction fragment under the control of a strong tardy promoter of the gene of at least one of the proteins associated with the baculovirus (polyedrine, protein P10). Process for obtaining such a modified baculovirus. Use of such a modified baculovirus as an unfilled expression vector ready to receive at least one sequence of at least one foreign gene which it is desired to express. <IMAGE>
Patent NZ-232124-A (NZ)
Title: Treatment of lignocellulosic material by activation with a gas containing nitrogen dioxide in the presence of nitrate; measuring acidity to control activation
Inventor: SAMUELSON HANS OLOF
IPC: D21C1/04
Filed: 1990-01-16
Abstract: The present invention solves the problem of delignifying technical cellulose pulp in a selective manner which will result in very low residual contents of lignin in the pulp and a correspondingly high quantity of lignin dissolved in spent liquors, which are recovered in the chemical recovery system of the pulp mill. The invention constitutes a method and comprises activating liquid-containing lignocellulosic material in the presence of nitrate with a gas that contains nitrogen dioxide, followed by the alkaline delignification of the lignocellulosic material, and measuring the acidity of the liquid accompanying the material on at least one occasion during the activation. The method is characterized in that the acidity of the liquid is measured subsequent to bringing the time derivative of the nitrate concentration of the liquid, expressed as millimols per litre of liquid per minute, to a level beneath +0.2, and by using the measured acidity value to establish the optimum amount of mineral acid for continuation and termination of the activation, and by charging the whole of this quantity or a part of this quantity of mineral acid to the lignocellulosic material.
Patent NZ-233582-A (NZ)
Title: Oral composition comprising alpha-galactosidase
Inventor: KLIGERMAN ALAN E
IPC: A23L1/305
Filed: 1990-05-07
Abstract: A composition is provided for ingestion by mammals for in vivo conversion of alpha-D-galactoside comprising an amount of alpha-galactosidase effective to hydrolyze alpha-D-galactoside to D-galactose, and non-toxic, ingestible excipients(s) for said alpha-galactrosidase. Gastric distress in mammals due to ingestion of foods containing alpha-D-galactoside may be reduced by ingesting the foregoing composition of alpha-galactosidase and non-toxic, ingestible excipient contemporaneously with the ingestion of said food in an amount effective to hydrolyze the alpha-D-galactoside to D-galactose.
Patent NZ-242101-A (NZ)
Title: A topical aqueous suspension of solid lipoid nanoparticles.
Inventor: DE VRINGER TOM
IPC: A61Q3/00
Filed: 1992-03-24
Abstract: An aqueous suspension of solid lipoid nanoparticles, comprising at least one lipid and preferably also at least one emulsifier, is provided for topical application to the body, wherein the lipid is a solid lipid, selected from the group consisting of:     higher saturated alcohols;   sphingolipids;   synthetic esters;   higher fatty acids of 12-30 carbon atoms and mono-, di- and triglycerides of higher saturated fatty acids having 10 - 30 carbon atoms.   Optionally the suspension of solid lipoid nanoparticles contains a drug. A manufacturing method for the said aqueous suspension of solid lipoid nanoparticles is also provided.
Patent NZ-246189-A (NZ)
Title: Railway fastening clip, anchoring device and method of assembly
Inventor: BROWN TREVOR PAUL
IPC: E01B9/48
Filed: 1992-12-18
Abstract: PCT No. PCT/GB92/02359 Sec. 371 Date Aug. 11, 1994 Sec. 102(e) Date Aug. 11, 1994 PCT Filed Dec. 18, 1992 PCT Pub. No. W093/12296 PCT Pub. Date Jun. 24, 1994.A railway rail fastening clip (1) suitable for holding down a railway rail (2) is formed from a rod of resilient material bent so as to be approximately M-shaped in plan, the clip (1) being such that, when it is bearing on the flange of a rail (2), the longitudinal axis of a part (14) thereof, which interconnects inner legs (13, 15) of the M, lies in a reference plane which is substantially parallel, but not identical, to a plane containing the longitudinal axes of outer legs (11, 17) of the M. Such clips (1) are used with an anchoring device (5), which, as the clip (1) is installed therein, deflects the outer legs (11, 17) downwardly with respect to the inner legs (13, 15), so as to place the clip under stress.
Patent NZ-289400-A (NZ)
Title: Self-release binder system comprising an organic polyisocyanate binder and a composition comprising a wax and a fatty acid; used for preparing molded lignocellulosic articles
Inventor: MARCINKO JOSEPH JOHN
IPC: C08G18/28
Filed: 1995-06-22
Abstract: A self-release binder system comprising (a) an organic polyisocyanate binder; and (b) a composition comprising (i) a wax and (ii) a fatty acid.
Patent NZ-292854-A (NZ)
Title: Use of an photoactive compound to treat multiple sclerosis which is followed by light therapy
Inventor: LEONG SIMON
IPC: F21V9/16
Filed: 1995-09-22
Abstract: A photoactive compound such as a porphyrin based compound is used in the manufacture of a medicament for reducing selectively the activated leukocyte cell population in a leukocyte containing fluid of a multiple sclerosis patient in need of such reduction by a) treating the fluid or an activated leukocyte containing fraction thereof with the medicament and b) irradiating the treated fluid or fraction thereof with non-UV light comprising at least one wavelength absorbed by the compound at intensity sufficient to activate the compound to effect its toxicity.  The above compound is used in the manufacture of a medicament for ameliorating the physiological effects of multiple sclerosis in a patient in need of such ameliorating by c) contacting blood or fraction thereof with the medicament and d) irradiating the blood fluid or fraction thereof with non-UV light absorbed by the compound at intensity sufficient to activate the compound to effect its toxicity and e) returning the treated blood or fraction thereof to the patient; or by f) administering the medicament to the patient to permit effectively distribution of the compound in the patient; g) allowing the distribution to occur and h) irradiating the patient with non-UV light absorbed by the compound at intensity sufficient to activate the compound to effect its toxicity.
Patent NZ-326145-A (NZ)
Title: Medical valve with fluid escape space comprises a body with a fluid escape space and cavity having a resilient seal and a spike with a tip having a hole
Inventor: LOPEZ GEORGE A
IPC: A61M39/10
Filed: 1996-12-16
Abstract: A medical valve has a body which includes a wall structure defining an internal cavity having an inside and an outside. The body also has a proximal end and a distal end. The proximal end has an opening sufficiently large to receive a tip of a delivery end of a medical implement which transfers fluid through the delivery end. The body has a fluid escape space in its wall structure. The valve also has a spike with a tip and at least one hole located at or near the tip. The spike has a passageway in communication with the hole that allows fluid to flow through the spike. A resilient seal in the cavity surrounds the spike. This seal is adapted to be moved into a compressed state upon insertion of the tip of the medical implement into the opening. The seal is sufficiently resilient to return to a decompressed state upon removal of the tip of the medical implement from the opening. The fluid escape space is in fluid communication with the outside of the cavity when the seal is in its compressed state.